Platelets in cancer and thrombosis.
1Cihan Ay, MD, Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria, Tel. +43/1/404 00 44 10, Fax +43/1/404 00 40 30,
Hamostaseologie
|December 6, 2013
Summary
Platelets, small blood cells crucial for hemostasis, also play a role in cancer progression and metastasis. Altered platelet function in cancer patients increases venous thromboembolism (VTE) risk and worsens prognosis.
Area of Science:
- Hematology
- Oncology
- Pathophysiology
Background:
- Platelets are essential for hemostasis, wound repair, and immune responses.
- Platelets contain granules releasing molecules vital for physiological processes.
- Platelets are implicated in cancer progression, promoting tumor growth, angiogenesis, and metastasis.
Purpose of the Study:
- To review alterations in platelet physiology specific to cancer patients.
- To explore how these platelet changes influence cancer progression.
- To examine the contribution of altered platelets to cancer-associated venous thromboembolism (VTE).
Main Methods:
- Literature review of studies on platelet function in cancer.
- Analysis of research linking platelet count and cancer prognosis.
- Synthesis of findings on platelet-mediated mechanisms in cancer and VTE.
Main Results:
- Platelets actively support tumor growth, angiogenesis, and metastasis.
- Cancer patients exhibit a hypercoagulable state linked to platelets.
- Elevated platelet counts correlate with increased VTE risk and poorer cancer prognosis.
Conclusions:
- Platelet alterations are significant in cancer pathophysiology.
- Modified platelet function contributes to cancer progression and VTE.
- Understanding these changes is crucial for managing cancer-associated thrombosis.
More Related Videos
Related Concept Videos
01:18Structure and Function of Platelets
7.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
7.1K
01:22Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
01:24Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:17Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
01:05Introduction to Hemostasis
14.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.2K